NCT00656370View on ClinicalTrials.gov

Study of Subcutaneous Hydration Enabled by Human Recombinant Hyaluronidase (Hylenex)

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

January 30, 2008

Study Completion Date

January 30, 2008

Conditions
Healthy
Interventions
DRUG

recombinant human hyaluronidase

150 Units in 1mL

Trial Locations (1)

49007

Jasper Clinic, Kalamazoo

Sponsors
All Listed Sponsors
collaborator

Baxter Healthcare Corporation

INDUSTRY

lead

Halozyme Therapeutics

INDUSTRY

NCT00656370 - Study of Subcutaneous Hydration Enabled by Human Recombinant Hyaluronidase (Hylenex) | Biotech Hunter | Biotech Hunter